Rizobacter Revenue and Competitors
Estimated Revenue & Valuation
- Rizobacter's estimated annual revenue is currently $15M per year.
- Rizobacter's estimated revenue per employee is $17,964
Employee Data
- Rizobacter has 835 Employees.
- Rizobacter grew their employee count by 6% last year.
Rizobacter's People
Name | Title | Email/Phone |
---|
Rizobacter Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | N/A | 5 | -29% | CA$1.4M | N/A |
#2 | N/A | 41 | -2% | N/A | N/A |
#3 | $7.5M | 80 | 27% | N/A | N/A |
#4 | $1.7M | 87 | 4% | N/A | N/A |
#5 | N/A | 13 | 0% | N/A | N/A |
#6 | $3.5M | 44 | 5% | N/A | N/A |
#7 | N/A | 28 | N/A | N/A | N/A |
#8 | N/A | 31 | -78% | N/A | N/A |
#9 | $3.5M | 52 | 8% | N/A | N/A |
#10 | $7.5M | 288 | 9% | N/A | N/A |
What Is Rizobacter?
Rizobacter is a leading company in microbiological products applied to agriculture helping to improve global food security by enabling millions of farmers to make better use of available resources in a sustainable way. With more than 40 years of experience Rizobacter technologies are being sold in 31 countries all around the world. Rizobacter is a company that combines the flexibility and fast decision of middle size company with state of the art R&D at the same level than the biggest players in the market place. Rizobacter is an Equal Opportunity Employer and does not discriminate in recruitment, hiring, training, promotion or any other employment practices for reasons of race, color, religion, gender, national origin, age, sexual orientation, marital or veteran status, disability, or any other legally protected status.
keywords:N/AN/A
Total Funding
835
Number of Employees
$15M
Revenue (est)
6%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Rizobacter News
Players profiled in the report: Novozymes, Biomax, RIZOBACTER, Agri Life, Symborg, National Fertilizers Limited, Batian, Xi'an Delong Bio-...
Biomax; RIZOBACTER; Agri Life; Symborg; National Fertilizers Limited; Batian; Xi'an Delong Bio-industry; Maboshi; Fertilzer King; Jinggeng...
Bioceres uses Rizobacter's profits and debt to fund its growth strategy based on HB4 technology and further acquisitions. The problem is that...